{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:17:15Z","timestamp":1790507835612,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.intimp.2023.110626","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T23:42:36Z","timestamp":1689378156000},"page":"110626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Increased serum interleukin-6 and lactate dehydrogenase levels among nonsurvival severe COVID-19 patients when compared to survival ones"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2382-0760","authenticated-orcid":false,"given":"Riham Abdel-Hamid","family":"Haroun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed H.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha E.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa M.","family":"Eessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soha","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110626_b0005","unstructured":"WHO Director-General\u2019s opening remarks at the media briefing on COVID-19 \u2013 11 March 2020: World Health Organization; 2020. Available: https:\/\/www.who.int\/directorgeneral\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefingon-covid-19---11-march-2020. [Accessed 26 Jun 2021]."},{"issue":"10223","key":"10.1016\/j.intimp.2023.110626_b0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"China. Lancet."},{"key":"10.1016\/j.intimp.2023.110626_b0015","unstructured":"COVID-19 coronavirus pandemic: Available: https:\/\/www.worldometers.info\/coronavirus\/ [Accessed December 09, 2022]."},{"issue":"8","key":"10.1016\/j.intimp.2023.110626_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100618","article-title":"COVID-19 and Multiorgan Response","volume":"45","author":"Zaim","year":"2020","journal-title":"Curr Probl Cardiol."},{"issue":"538","key":"10.1016\/j.intimp.2023.110626_b0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbrc.2020.10.069","article-title":"Laboratory testing for the diagnosis of COVID-19","volume":"29","author":"Lai","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2023.110626_b0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/bmjebm-2020-111536","article-title":"Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and metaanalysis","volume":"26","author":"Malik","year":"2021","journal-title":"BMJ Evid. Based Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.110626_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2146","article-title":"Predictors of COVID-19 severity: A literature review","volume":"31","author":"Gallo Marin","year":"2021","journal-title":"Rev. Med. Virol."},{"issue":"7816","key":"10.1016\/j.intimp.2023.110626_b0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2355-0","article-title":"Viral and host factors related to the clinical outcome of COVID-19","volume":"583","author":"Zhang","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.intimp.2023.110626_b0045","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijid.2020.04.061","article-title":"Mild versus severe COVID-19: Laboratory markers","volume":"95","author":"Velavan","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.intimp.2023.110626_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.03.005","article-title":"Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients","volume":"80","author":"Liu","year":"2020","journal-title":"J. Infect."},{"issue":"7","key":"10.1016\/j.intimp.2023.110626_b0055","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1515\/cclm-2020-0285","article-title":"Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)","volume":"58","author":"Lippi","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.110626_b0060","first-page":"4","volume":"7","author":"Jin","year":"2020","journal-title":"Mil Med Res"},{"key":"10.1016\/j.intimp.2023.110626_b0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cca.2020.03.004","article-title":"Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis","volume":"505","author":"Lippi","year":"2020","journal-title":"Clin. Chim. Acta."},{"issue":"269","key":"10.1016\/j.intimp.2023.110626_b0070","article-title":"Interferon-\u03b3-induced protein 10 (IP-10) and serum amyloid A (SAA) are excellent biomarkers for the prediction of COVID-19 progression and severity","volume":"15","author":"Haroun","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.110626_b0075","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pathol.2021.09.006","article-title":"Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection","volume":"54","author":"Haroun","year":"2022","journal-title":"Pathology"},{"key":"10.1016\/j.intimp.2023.110626_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2021.101679","article-title":"Evaluation of serum total sialic acid in moderate COVID-19 patients with and without gastrointestinal tract manifestations","volume":"74","author":"Haroun","year":"2022","journal-title":"Tissue Cell."},{"key":"10.1016\/j.intimp.2023.110626_b0085","unstructured":"Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 41 (2) (2020 Feb 10) 145\u2013151. Chinese. doi: 10.3760\/cma.j.issn.0254-6450.2020.02.003. PMID: 32064853."},{"issue":"5","key":"10.1016\/j.intimp.2023.110626_b0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"7","key":"10.1016\/j.intimp.2023.110626_b0095","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jmv.25770","article-title":"Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19","volume":"92","author":"Gao","year":"2020","journal-title":"J. Med. Virol."},{"issue":"15","key":"10.1016\/j.intimp.2023.110626_b0100","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cid\/ciaa272","article-title":"Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China","volume":"71","author":"Wang","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2023.110626_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19","volume":"127","author":"Liu","year":"2020","journal-title":"J. Clin. Virol."},{"issue":"15","key":"10.1016\/j.intimp.2023.110626_b0110","doi-asserted-by":"crossref","first-page":"15670","DOI":"10.18632\/aging.103770","article-title":"Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19","volume":"12","author":"Li","year":"2020","journal-title":"Aging (Albany NY)."},{"issue":"1","key":"10.1016\/j.intimp.2023.110626_b0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.110626_b0120","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijid.2020.04.041","article-title":"Clinical value of immune inflammatory parameters to assess the severity of coronavirus disease 2019","volume":"95","author":"Zhu","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.intimp.2023.110626_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2141","article-title":"Interleukin-6 in Covid-19: A systematic review and metaanalysis","volume":"30","author":"Coomes","year":"2020","journal-title":"Rev. Med. Virol."},{"issue":"10224","key":"10.1016\/j.intimp.2023.110626_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30305-6","article-title":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option","volume":"395","author":"Zumla","year":"2020","journal-title":"Lancet."},{"issue":"5","key":"10.1016\/j.intimp.2023.110626_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.1016\/j.intimp.2023.110626_b0140","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012645","article-title":"Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis","author":"Komolafe","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.intimp.2023.110626_b0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2020.06.012","article-title":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients","volume":"509","author":"Poggiali","year":"2020","journal-title":"Clin. Chim. Acta."},{"issue":"8","key":"10.1016\/j.intimp.2023.110626_b0150","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4161\/cc.10.8.15330","article-title":"Ketones and lactate increase cancer cell \u201cstemness,\u201d driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics","volume":"10","author":"Martinez-Outschoorn","year":"2011","journal-title":"Cell Cycle."},{"issue":"9","key":"10.1016\/j.intimp.2023.110626_b0155","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.ajem.2020.05.073","article-title":"Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis","volume":"38","author":"Henry","year":"2020","journal-title":"Am. J. Emerg. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.110626_b0160","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","volume":"146","author":"Li","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110626_b0165","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s10753-022-01680-7","article-title":"The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients","volume":"45","author":"Gupta","year":"2022","journal-title":"Inflammation."},{"issue":"2020","key":"10.1016\/j.intimp.2023.110626_b0170","first-page":"4743904","article-title":"Lactate Arterial-Central Venous Gradient among COVID-19 Patients in ICU: A Potential Tool in the Clinical Practice","volume":"25","author":"Nardi","year":"2020","journal-title":"Crit. Care Res. Pract."},{"issue":"1","key":"10.1016\/j.intimp.2023.110626_b0175","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41467-020-14433-7","article-title":"Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase","volume":"11","author":"Palmieri","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.intimp.2023.110626_b0180","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"58","author":"Henry","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.intimp.2023.110626_b0185","doi-asserted-by":"crossref","first-page":"e12967","DOI":"10.1111\/sji.12967","article-title":"Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms","volume":"93","author":"Jafarzadeh","year":"2021","journal-title":"Scand J. Immunol."},{"key":"10.1016\/j.intimp.2023.110626_b0190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijid.2020.04.086","article-title":"Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis","volume":"96","author":"Zhao","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.intimp.2023.110626_b0195","doi-asserted-by":"crossref","first-page":"e0142203","DOI":"10.1371\/journal.pone.0142203","article-title":"Monocyte Caspase-1 Is Released in a Stable, Active High Molecular Weight Complex Distinct from the Unstable Cell Lysate-Activated Caspase-1","volume":"10","author":"Shamaa","year":"2015","journal-title":"PLoS One."},{"issue":"2","key":"10.1016\/j.intimp.2023.110626_b0200","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: host cell death and inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110626_b0205","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/biom12030442","article-title":"Upregulated Proteasome Subunits in COVID-19 Patients: A Link with Hypoxemia, Lymphopenia and Inflammation","volume":"12","author":"Alfaro","year":"2022","journal-title":"Biomolecules."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923009517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923009517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T09:25:48Z","timestamp":1736414748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923009517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":41,"alternative-id":["S1567576923009517"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110626","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased serum interleukin-6 and lactate dehydrogenase levels among nonsurvival severe COVID-19 patients when compared to survival ones","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110626"}}